These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methaemoglobinaemia and haemolysis following pegloticase infusion for refractory gout in a patient with a falsely negative glucose-6-phosphate dehydrogenase deficiency result. Geraldino-Pardilla L; Sung D; Xu JZ; Shirazi M; Hod EA; Francis RO Rheumatology (Oxford); 2014 Dec; 53(12):2310-1. PubMed ID: 25224415 [No Abstract] [Full Text] [Related]
3. Hemolytic Anemia Induced by Pegloticase Infusion in a Patient With G6PD Deficiency. Owens RE; Swanson H; Twilla JD J Clin Rheumatol; 2016 Mar; 22(2):97-8. PubMed ID: 26906307 [No Abstract] [Full Text] [Related]
4. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout. Biggers K; Scheinfeld N Curr Opin Investig Drugs; 2008 Apr; 9(4):422-9. PubMed ID: 18393109 [TBL] [Abstract][Full Text] [Related]
5. Pegloticase hypersensitivity desensitisation: an outpatient, 3-bag, 12-step protocol. Botson JK BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32565437 [TBL] [Abstract][Full Text] [Related]
6. Pegloticase: withdrawal of its European marketing authorisation is welcome. Prescrire Int; 2017 Mar; 26(180):71. PubMed ID: 30730621 [No Abstract] [Full Text] [Related]
7. [Gout and other crystal-induced arthritides]. Manger B Dtsch Med Wochenschr; 2012 Aug; 137(31-32):1579-81. PubMed ID: 22786675 [No Abstract] [Full Text] [Related]
8. Rasburicase-induced methaemoglobinaemia and G6PD deficiency in an unusual suspect. Oluwasanjo A; Alese O; Swierczynski S; Forman D Br J Haematol; 2015 Sep; 170(5):595. PubMed ID: 26033222 [No Abstract] [Full Text] [Related]
9. Pegloticase for treatment of tophaceous polyarticular gout. Seifried RM; Roberts J Hawaii J Med Public Health; 2013 Jul; 72(7):220-3. PubMed ID: 23901393 [TBL] [Abstract][Full Text] [Related]
10. Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout. Calabrese LH; Kavanaugh A; Yeo AE; Lipsky PE Arthritis Res Ther; 2017 Aug; 19(1):191. PubMed ID: 28818095 [TBL] [Abstract][Full Text] [Related]
11. Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy. Baraf HS; Yood RA; Ottery FD; Sundy JS; Becker MA J Clin Rheumatol; 2014 Dec; 20(8):427-32. PubMed ID: 25417679 [TBL] [Abstract][Full Text] [Related]